Edition:
United Kingdom

Nichi-Iko Pharmaceutical Co Ltd (4541.T)

4541.T on Tokyo Stock Exchange

1,768JPY
4:35am BST
Change (% chg)

¥40 (+2.31%)
Prev Close
¥1,728
Open
¥1,732
Day's High
¥1,768
Day's Low
¥1,727
Volume
293,300
Avg. Vol
336,442
52-wk High
¥1,895
52-wk Low
¥1,570

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold -- March 26 Apr 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 2 1 1 1
(3) HOLD 3 3 3 3
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.60 2.75 2.75 2.75

Consensus Estimates Analysis

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Year Ending Mar-18 5 189,540.00 200,900.00 169,000.00 213,660.00
Year Ending Mar-19 5 204,560.00 226,400.00 175,000.00 237,400.00
Earnings (per share)
Year Ending Mar-18 6 112.46 136.88 98.50 140.05
Year Ending Mar-19 6 129.38 152.87 108.84 159.03
LT Growth Rate (%) 1 21.16 21.16 21.16 --

Historical Surprises

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 51,487.00 45,784.00 5,703.00 11.08
Quarter Ending Mar-17 50,425.00 46,097.00 4,328.00 8.58
Quarter Ending Mar-16 34,480.00 35,193.00 713.00 2.07
Quarter Ending Sep-15 34,451.00 33,938.00 513.00 1.49
Quarter Ending Jun-15 33,266.00 35,049.00 1,783.00 5.36

Consensus Estimates Trend

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Year Ending Mar-18 189,540.00 189,540.00 188,750.00 191,150.00 213,660.00
Year Ending Mar-19 204,560.00 204,560.00 203,975.00 206,025.00 237,400.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Year Ending Mar-18 0 0 0 0
Year Ending Mar-19 0 0 0 0
Earnings